Aripiprazole Oral solution 50ml:50mg
You are here: Home » Products » Finished Preparation » Mental Nerves Drugs » Aripiprazole Oral Solution » Aripiprazole Oral solution 50ml:50mg

loading

Aripiprazole Oral solution 50ml:50mg

Dosage Form: Oral solution 
Strength: 50ml:50mg
Indications: Schizophrenia
Shelf Life: 3 years
Availability:
Quantity:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

Mechanism of Action: 

Aripiprazole is an atypical antipsychotic that works by modulating the activity of dopamine and serotonin receptors in the brain. It is used to treat various mental health conditions, including schizophrenia, bipolar disorder, and major depressive disorder.

Indications:

  • Schizophrenia: Aripiprazole is used in the treatment of schizophrenia.

  • Bipolar Disorder: It may be prescribed for the acute treatment of manic and mixed episodes associated with bipolar disorder.

  • Major Depressive Disorder (as an adjunct): Aripiprazole may be used as an adjunct to antidepressants for the treatment of major depressive disorder.

Administration: 

The liquid formulation is typically administered orally, and the dosage instructions would depend on the patient's condition, medical history, and other factors.

Side Effects: 

Common side effects may include weight gain, drowsiness, and extrapyramidal symptoms (involuntary movements). Patients should be aware of potential side effects and report any unusual or severe reactions to their healthcare provider.

Precautions and Contraindications:

  • Aripiprazole may interact with certain medications, and patients should inform their healthcare provider about all the medications they are taking.

  • It is not recommended for individuals with a known hypersensitivity to aripiprazole.

 Warnings:

Patients should be monitored for signs of suicidal thoughts, changes in mood or behavior, and metabolic effects such as hyperglycemia and dyslipidemia.


Related News

content is empty!

Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.

QUICK LINKS

PRODUCT CATEGORY

Copyright © 2023 Shandong Loncom Pharmaceutical Co., Ltd. All Rights Reserved. Sitemap | Privacy Policy
Supported by leadong.com
Contact Us